Comparison Between Pupillometry and the Numerical Rating Scale
NCT ID: NCT05019898
Last Updated: 2021-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
320 participants
INTERVENTIONAL
2021-08-04
2022-08-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pupil Dilation and Analgesia Nociception Index
NCT03280238
Experimental Pain Reporting Accuracy and Clinical Post-operative Pain
NCT03854669
Validation and Pertinence of Anxiety Analogic Visual Scale in Pain Management
NCT02690597
Skin Conductance Fluctuations Per Sec and NRS to Monitor Pain
NCT01865344
Therapeutic Strategies During Exposure to Pain in an Experimental Design
NCT03146832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic Test: pupillometry
pupillometry
Step 1: The triage will be carried out by the nurse. The nurse will then perform a self-assessment of the patient's pain using a simple verbal scale.
The nurse will then record the patient's self-assessment of his pain using the numeric scale for pain.
Step 2: Immediately after this first assessment, eligible patients will be approached by the study investigator to be included in the study.
Step 3: If the patient gives informed consent, the study investigator will perform
* The quantification of their anxiety
* An assessment of pain by a NeuroLight videopupillometer (iDmed, Marseille, France) using two dynamic tests, the Pupillary Unrest in Ambient Light (PUAL) and the pupillary light reflex.
Step 4: One hour after the triage, a second pain assessment will be performed. Step 5: The same pupillometry measurements will be taken immediately after the nurse has assessed the pain.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pupillometry
Step 1: The triage will be carried out by the nurse. The nurse will then perform a self-assessment of the patient's pain using a simple verbal scale.
The nurse will then record the patient's self-assessment of his pain using the numeric scale for pain.
Step 2: Immediately after this first assessment, eligible patients will be approached by the study investigator to be included in the study.
Step 3: If the patient gives informed consent, the study investigator will perform
* The quantification of their anxiety
* An assessment of pain by a NeuroLight videopupillometer (iDmed, Marseille, France) using two dynamic tests, the Pupillary Unrest in Ambient Light (PUAL) and the pupillary light reflex.
Step 4: One hour after the triage, a second pain assessment will be performed. Step 5: The same pupillometry measurements will be taken immediately after the nurse has assessed the pain.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Consent impossible to obtain (cognitive disorders, language barrier…).
* Patient taking immediate-release opioid medication (last dose within the last 12 hours).
* Patient taking prolonged-release opioid medication (last dose within the last 24 hours).
* Basic treatment with a dopaminergic D2 antagonist (antipsychotic drugs).
* Basic treatment with dopamine antagonist antiemetic medication (metoclopramide (T1/2 5-6h), domperidone (T1/2 7-9h), alizapride (T1/2 3h)) within the last 12 hours.
* Patient taking clonidine (last dose within the last 24 hours).
* Use of topical ocular drugs modifying pupillary parameters in the last 24 hours.
* Bilateral eye surgery modifying the possibilities of variation in pupillary diameter bilaterally.
* Parkinson's or Alzheimer's disease at a dysautonomic stage.
* Admission to the emergency room for acute ocular pathology.
* History of diabetes at a dysautonomic stage.
* History of alcoholism at a dysautonomic stage.
* History of glaucoma.
* Pregnant patient with preeclampsia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
cliniques universitaires Saint-Luc
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Gregoire C, Charier D, de Bergeyck R, Mouraux A, Van Ouytsel F, Lambert R, Zhou N, Lavand'homme P, Penaloza A, Pickering G. Comparison between pupillometry and numeric pain rating scale for pain assessments in communicating adult patients in the emergency department. Eur J Pain. 2023 Sep;27(8):952-960. doi: 10.1002/ejp.2137. Epub 2023 Jun 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEWC_MAYS2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.